Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Andrew Scheibe, Katherine Young, Lorraine Moses, Rudolph L Basson, Anna Versfeld, C Wendy Spearman, Mark W Sonderup, Nishi Prabdial-Sing, Jack Manamela, Adrian J Puren, Kevin Rebe, Harry Hausler

ABSTRACT

BACKGROUND: People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence and risk factors among PWID accessing harm reduction services in Cape Town, Durban and Pretoria to inform policy and programming. METHODS: We conducted a cross-sectional survey among PWID in these cities between August 2016 and October 2017. Participants were opportunistically sampled while accessing services. Study team members administered a questionnaire that assessed sociodemographic characteristics, drug use and sexual risk practices. We tested for HCV (antibody, viral load and genotype), HBV surface antigen (HBsAg) and HIV. Bivariate and multivariate analyses assessed associations with HCV serostatus. RESULTS: Nine hundred and forty-three PWID were included in the per protocol analysis. The majority (87%, 819/943) were male, the overall median age was 29 and most lived on the street (66%, 626/943). At last injection, 77% (722/943) reported using a new needle and syringe and 17% (163/943) shared equipment. HIV prevalence was 21% (196/926), HBsAg positivity 5% (47/936), HCV seroprevalence 55% (513/937), HCV viraemic prevalence (proportion tested with detectable HCV) 43% (404/937) and HCV viraemic rate (proportion HCV antibody positive with detectable HCV) 79% (404/513). HCV genotype 1a (73%, 270/368) was the most prevalent. In multivariate analysis, HCV infection was positively associated with residing in Pretoria (adjusted odds ratio (aOR) 1.27, 95% CI 1.21-1.34), living on the street (aOR 1.90, 95% CI 1.38-2.60), frequent injecting (aOR 1.58, 95% CI 1.15-2.16) and HIV infection (aOR 1.69, 95% CI 1.15-2.47), and negatively associated with black race (aOR 0.52, 95% CI 0.36-0.74) and sexual activity in the previous month (aOR 0.61, 95% CI 0.42-0.88). CONCLUSIONS: HCV and HIV are major health threats affecting PWID in these cities. Access to OST and needle and syringe services needs to be increased and integrated with HCV services. Social and structural factors affecting PWID who live on the street need to be addressed. More... »

PAGES

28

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12954-019-0298-2

DOI

http://dx.doi.org/10.1186/s12954-019-0298-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113377852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30975139


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "TB HIV Care, 11 Adderley Street, Cape Town, South Africa. andrew.scheibe@gmail.com."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheibe", 
        "givenName": "Andrew", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "TB HIV Care, 11 Adderley Street, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Young", 
        "givenName": "Katherine", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "IQVIA South Africa, CX Building 1021 Lenchen Ave North, Centurion, Pretoria, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moses", 
        "givenName": "Lorraine", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "TB HIV Care, 11 Adderley Street, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basson", 
        "givenName": "Rudolph L", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "TB HIV Care, 11 Adderley Street, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Versfeld", 
        "givenName": "Anna", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Groote Schuur Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413335.3", 
          "name": [
            "Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spearman", 
        "givenName": "C Wendy", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Groote Schuur Hospital", 
          "id": "https://www.grid.ac/institutes/grid.413335.3", 
          "name": [
            "Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sonderup", 
        "givenName": "Mark W", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of the Witwatersrand", 
          "id": "https://www.grid.ac/institutes/grid.11951.3d", 
          "name": [
            "National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.", 
            "Division of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Prabdial-Sing", 
        "givenName": "Nishi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Health Laboratory Service", 
          "id": "https://www.grid.ac/institutes/grid.416657.7", 
          "name": [
            "National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Manamela", 
        "givenName": "Jack", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of the Witwatersrand", 
          "id": "https://www.grid.ac/institutes/grid.11951.3d", 
          "name": [
            "National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.", 
            "Division of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Puren", 
        "givenName": "Adrian J", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Anova Health Institute", 
          "id": "https://www.grid.ac/institutes/grid.452200.1", 
          "name": [
            "Division of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.", 
            "Anova Health Institute, 12 Sherborne Road, Parktown, Johannesburg, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rebe", 
        "givenName": "Kevin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "TB HIV Care, 11 Adderley Street, Cape Town, South Africa."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hausler", 
        "givenName": "Harry", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.jcv.2014.05.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009645202"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(10)60743-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010459885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2013.03.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015042719"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0109282", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016621925"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0103345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019293991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0103345", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019293991"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10461-013-0593-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020487771", 
          "https://doi.org/10.1007/s10461-013-0593-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2015.09.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031167283"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijid.2010.06.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033372477"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jvh.12571", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039080936"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/ije/dyr050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040398875"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugpo.2016.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042879889"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7517-10-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045255166", 
          "https://doi.org/10.1186/1477-7517-10-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhep.2016.07.042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047496931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugpo.2016.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051290979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.vaccine.2012.02.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052670546"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7517-10-13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053050984", 
          "https://doi.org/10.1186/1477-7517-10-13"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1363459316660859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063997608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1363459316660859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063997608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1363459316660859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063997608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2214-109x(17)30375-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092329959"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2214-109x(17)30373-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092332693"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2468-1253(17)30249-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092596895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s2468-1253(17)30295-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092596896"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7196/samj.2017.v107i12.12623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100454929"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.drugalcdep.2018.05.030", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1105468279"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence and risk factors among PWID accessing harm reduction services in Cape Town, Durban and Pretoria to inform policy and programming.\nMETHODS: We conducted a cross-sectional survey among PWID in these cities between August 2016 and October 2017. Participants were opportunistically sampled while accessing services. Study team members administered a questionnaire that assessed sociodemographic characteristics, drug use and sexual risk practices. We tested for HCV (antibody, viral load and genotype), HBV surface antigen (HBsAg) and HIV. Bivariate and multivariate analyses assessed associations with HCV serostatus.\nRESULTS: Nine hundred and forty-three PWID were included in the per protocol analysis. The majority (87%, 819/943) were male, the overall median age was 29 and most lived on the street (66%, 626/943). At last injection, 77% (722/943) reported using a new needle and syringe and 17% (163/943) shared equipment. HIV prevalence was 21% (196/926), HBsAg positivity 5% (47/936), HCV seroprevalence 55% (513/937), HCV viraemic prevalence (proportion tested with detectable HCV) 43% (404/937) and HCV viraemic rate (proportion HCV antibody positive with detectable HCV) 79% (404/513). HCV genotype 1a (73%, 270/368) was the most prevalent. In multivariate analysis, HCV infection was positively associated with residing in Pretoria (adjusted odds ratio (aOR) 1.27, 95% CI 1.21-1.34), living on the street (aOR 1.90, 95% CI 1.38-2.60), frequent injecting (aOR 1.58, 95% CI 1.15-2.16) and HIV infection (aOR 1.69, 95% CI 1.15-2.47), and negatively associated with black race (aOR 0.52, 95% CI 0.36-0.74) and sexual activity in the previous month (aOR 0.61, 95% CI 0.42-0.88).\nCONCLUSIONS: HCV and HIV are major health threats affecting PWID in these cities. Access to OST and needle and syringe services needs to be increased and integrated with HCV services. Social and structural factors affecting PWID who live on the street need to be addressed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12954-019-0298-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031325", 
        "issn": [
          "1477-7517"
        ], 
        "name": "Harm Reduction Journal", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.", 
    "pagination": "28", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12954-019-0298-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113377852"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101153624"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30975139"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12954-019-0298-2", 
      "https://app.dimensions.ai/details/publication/pub.1113377852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-16T06:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000377_0000000377/records_106840_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12954-019-0298-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12954-019-0298-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12954-019-0298-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12954-019-0298-2'


 

This table displays all metadata directly associated to this object as RDF triples.

224 TRIPLES      21 PREDICATES      51 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12954-019-0298-2 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nbb49f22dceba42b7a1690d4f0c3d3a09
4 schema:citation sg:pub.10.1007/s10461-013-0593-y
5 sg:pub.10.1186/1477-7517-10-13
6 sg:pub.10.1186/1477-7517-10-7
7 https://doi.org/10.1016/j.drugalcdep.2013.03.009
8 https://doi.org/10.1016/j.drugalcdep.2015.09.025
9 https://doi.org/10.1016/j.drugalcdep.2018.05.030
10 https://doi.org/10.1016/j.drugpo.2016.01.004
11 https://doi.org/10.1016/j.drugpo.2016.01.012
12 https://doi.org/10.1016/j.ijid.2010.06.013
13 https://doi.org/10.1016/j.jcv.2014.05.018
14 https://doi.org/10.1016/j.jhep.2016.07.042
15 https://doi.org/10.1016/j.vaccine.2012.02.021
16 https://doi.org/10.1016/s0140-6736(10)60743-x
17 https://doi.org/10.1016/s2214-109x(17)30373-x
18 https://doi.org/10.1016/s2214-109x(17)30375-3
19 https://doi.org/10.1016/s2468-1253(17)30249-2
20 https://doi.org/10.1016/s2468-1253(17)30295-9
21 https://doi.org/10.1093/ije/dyr050
22 https://doi.org/10.1111/jvh.12571
23 https://doi.org/10.1177/1363459316660859
24 https://doi.org/10.1371/journal.pone.0103345
25 https://doi.org/10.1371/journal.pone.0109282
26 https://doi.org/10.7196/samj.2017.v107i12.12623
27 schema:datePublished 2019-12
28 schema:datePublishedReg 2019-12-01
29 schema:description BACKGROUND: People who inject drugs (PWID) are at high risk for hepatitis C (HCV), hepatitis B (HBV) and HIV without accessible harm reduction programmes. Coverage of needle and syringe and opioid substitution therapy (OST) services in South Africa is below global recommendations and no hepatitis services exist for PWID. We assessed HCV, HBV and HIV prevalence and risk factors among PWID accessing harm reduction services in Cape Town, Durban and Pretoria to inform policy and programming. METHODS: We conducted a cross-sectional survey among PWID in these cities between August 2016 and October 2017. Participants were opportunistically sampled while accessing services. Study team members administered a questionnaire that assessed sociodemographic characteristics, drug use and sexual risk practices. We tested for HCV (antibody, viral load and genotype), HBV surface antigen (HBsAg) and HIV. Bivariate and multivariate analyses assessed associations with HCV serostatus. RESULTS: Nine hundred and forty-three PWID were included in the per protocol analysis. The majority (87%, 819/943) were male, the overall median age was 29 and most lived on the street (66%, 626/943). At last injection, 77% (722/943) reported using a new needle and syringe and 17% (163/943) shared equipment. HIV prevalence was 21% (196/926), HBsAg positivity 5% (47/936), HCV seroprevalence 55% (513/937), HCV viraemic prevalence (proportion tested with detectable HCV) 43% (404/937) and HCV viraemic rate (proportion HCV antibody positive with detectable HCV) 79% (404/513). HCV genotype 1a (73%, 270/368) was the most prevalent. In multivariate analysis, HCV infection was positively associated with residing in Pretoria (adjusted odds ratio (aOR) 1.27, 95% CI 1.21-1.34), living on the street (aOR 1.90, 95% CI 1.38-2.60), frequent injecting (aOR 1.58, 95% CI 1.15-2.16) and HIV infection (aOR 1.69, 95% CI 1.15-2.47), and negatively associated with black race (aOR 0.52, 95% CI 0.36-0.74) and sexual activity in the previous month (aOR 0.61, 95% CI 0.42-0.88). CONCLUSIONS: HCV and HIV are major health threats affecting PWID in these cities. Access to OST and needle and syringe services needs to be increased and integrated with HCV services. Social and structural factors affecting PWID who live on the street need to be addressed.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree true
33 schema:isPartOf N5e8daae193744b75ab5062280d2a44a9
34 Ne99cf83192f647d6bd0f883dcad0686b
35 sg:journal.1031325
36 schema:name Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey.
37 schema:pagination 28
38 schema:productId N170db5306ce34e11b8fc6efcd8483c06
39 N312831d36c5040a6a90bcd5259d3405c
40 Nb403cc292a924f619819c8464fa07c3a
41 Ne234694a98194b3ea1490ac11d0a535e
42 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113377852
43 https://doi.org/10.1186/s12954-019-0298-2
44 schema:sdDatePublished 2019-04-16T06:25
45 schema:sdLicense https://scigraph.springernature.com/explorer/license/
46 schema:sdPublisher N65d58f7fd3094c03a225a27f659d29f2
47 schema:url https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0298-2
48 sgo:license sg:explorer/license/
49 sgo:sdDataset articles
50 rdf:type schema:ScholarlyArticle
51 N0270cb35aaa247fc96a9a6a690ebdc85 schema:affiliation N392de86dbe764f21aead23cde2992460
52 schema:familyName Scheibe
53 schema:givenName Andrew
54 rdf:type schema:Person
55 N0aff40602f4d40ae9f47f848dbe35403 rdf:first Nab974d3b01d247dd88fc52729e5308e2
56 rdf:rest Ne21a422d432c4550bad63d44bc9fb6f6
57 N139bd27a36234011a398ceadc29bb7bc rdf:first Nefae43996e724a2a9942dae07b9c74ec
58 rdf:rest N9025ba5f9fc04886a71818b469ce0b2b
59 N170db5306ce34e11b8fc6efcd8483c06 schema:name nlm_unique_id
60 schema:value 101153624
61 rdf:type schema:PropertyValue
62 N26f5c05681c547228676f55b1096fb72 schema:affiliation https://www.grid.ac/institutes/grid.413335.3
63 schema:familyName Spearman
64 schema:givenName C Wendy
65 rdf:type schema:Person
66 N312831d36c5040a6a90bcd5259d3405c schema:name doi
67 schema:value 10.1186/s12954-019-0298-2
68 rdf:type schema:PropertyValue
69 N31ca21dd2e99404d960033abfb211cbd rdf:first N26f5c05681c547228676f55b1096fb72
70 rdf:rest N0aff40602f4d40ae9f47f848dbe35403
71 N392de86dbe764f21aead23cde2992460 schema:name TB HIV Care, 11 Adderley Street, Cape Town, South Africa. andrew.scheibe@gmail.com.
72 rdf:type schema:Organization
73 N43732b400c7840d3a2dbf0354098670d schema:name IQVIA South Africa, CX Building 1021 Lenchen Ave North, Centurion, Pretoria, South Africa.
74 rdf:type schema:Organization
75 N4626cc08488947e89a5e9fd4735fdb1f schema:affiliation https://www.grid.ac/institutes/grid.11951.3d
76 schema:familyName Puren
77 schema:givenName Adrian J
78 rdf:type schema:Person
79 N5e8daae193744b75ab5062280d2a44a9 schema:volumeNumber 16
80 rdf:type schema:PublicationVolume
81 N65d58f7fd3094c03a225a27f659d29f2 schema:name Springer Nature - SN SciGraph project
82 rdf:type schema:Organization
83 N6c687c4c0859440588f0efeaa671c09b schema:name TB HIV Care, 11 Adderley Street, Cape Town, South Africa.
84 rdf:type schema:Organization
85 N7ac784f62f924f938059ca37cb8ef215 schema:affiliation N813026750a424f86a88bafad4f467ffb
86 schema:familyName Basson
87 schema:givenName Rudolph L
88 rdf:type schema:Person
89 N7e8cd332d4a14e00be697c88ce8a5e6e rdf:first Nb26e6d96164f4ef5b0bc931b4b2a9d20
90 rdf:rest N139bd27a36234011a398ceadc29bb7bc
91 N813026750a424f86a88bafad4f467ffb schema:name TB HIV Care, 11 Adderley Street, Cape Town, South Africa.
92 rdf:type schema:Organization
93 N9025ba5f9fc04886a71818b469ce0b2b rdf:first N7ac784f62f924f938059ca37cb8ef215
94 rdf:rest Nae40382d421b4cae830a373e58029405
95 N913be7bdc62b4804839dfb03aeacc450 schema:affiliation Nd6b3f57798054f6a873985c662a39f05
96 schema:familyName Hausler
97 schema:givenName Harry
98 rdf:type schema:Person
99 N9581b0fcac474cdd9f05602ed8f6cca4 rdf:first Nf5c9425a30624da1bf87dd130b666d12
100 rdf:rest Ncf768d5229da497391234367cb28b47b
101 N9f81b9e3cc6447388248764d375fdb0d rdf:first N4626cc08488947e89a5e9fd4735fdb1f
102 rdf:rest N9581b0fcac474cdd9f05602ed8f6cca4
103 Nab974d3b01d247dd88fc52729e5308e2 schema:affiliation https://www.grid.ac/institutes/grid.413335.3
104 schema:familyName Sonderup
105 schema:givenName Mark W
106 rdf:type schema:Person
107 Nae40382d421b4cae830a373e58029405 rdf:first Nd2c85c27578a46909a897028affce217
108 rdf:rest N31ca21dd2e99404d960033abfb211cbd
109 Nb26e6d96164f4ef5b0bc931b4b2a9d20 schema:affiliation N6c687c4c0859440588f0efeaa671c09b
110 schema:familyName Young
111 schema:givenName Katherine
112 rdf:type schema:Person
113 Nb403cc292a924f619819c8464fa07c3a schema:name pubmed_id
114 schema:value 30975139
115 rdf:type schema:PropertyValue
116 Nbb49f22dceba42b7a1690d4f0c3d3a09 rdf:first N0270cb35aaa247fc96a9a6a690ebdc85
117 rdf:rest N7e8cd332d4a14e00be697c88ce8a5e6e
118 Ncf768d5229da497391234367cb28b47b rdf:first N913be7bdc62b4804839dfb03aeacc450
119 rdf:rest rdf:nil
120 Nd2c85c27578a46909a897028affce217 schema:affiliation Nf89a3503675748889a035c19d4e60af9
121 schema:familyName Versfeld
122 schema:givenName Anna
123 rdf:type schema:Person
124 Nd6b3f57798054f6a873985c662a39f05 schema:name TB HIV Care, 11 Adderley Street, Cape Town, South Africa.
125 rdf:type schema:Organization
126 Ndb8d2fbd7ea1490387d6cb5775cc6d2a rdf:first Nf96afcf4970f48db94d53a7bcdc34dd6
127 rdf:rest N9f81b9e3cc6447388248764d375fdb0d
128 Ne21a422d432c4550bad63d44bc9fb6f6 rdf:first Ne5cd0264fd9f498b951189651cac6d4b
129 rdf:rest Ndb8d2fbd7ea1490387d6cb5775cc6d2a
130 Ne234694a98194b3ea1490ac11d0a535e schema:name dimensions_id
131 schema:value pub.1113377852
132 rdf:type schema:PropertyValue
133 Ne5cd0264fd9f498b951189651cac6d4b schema:affiliation https://www.grid.ac/institutes/grid.11951.3d
134 schema:familyName Prabdial-Sing
135 schema:givenName Nishi
136 rdf:type schema:Person
137 Ne99cf83192f647d6bd0f883dcad0686b schema:issueNumber 1
138 rdf:type schema:PublicationIssue
139 Nefae43996e724a2a9942dae07b9c74ec schema:affiliation N43732b400c7840d3a2dbf0354098670d
140 schema:familyName Moses
141 schema:givenName Lorraine
142 rdf:type schema:Person
143 Nf5c9425a30624da1bf87dd130b666d12 schema:affiliation https://www.grid.ac/institutes/grid.452200.1
144 schema:familyName Rebe
145 schema:givenName Kevin
146 rdf:type schema:Person
147 Nf89a3503675748889a035c19d4e60af9 schema:name TB HIV Care, 11 Adderley Street, Cape Town, South Africa.
148 rdf:type schema:Organization
149 Nf96afcf4970f48db94d53a7bcdc34dd6 schema:affiliation https://www.grid.ac/institutes/grid.416657.7
150 schema:familyName Manamela
151 schema:givenName Jack
152 rdf:type schema:Person
153 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
154 schema:name Medical and Health Sciences
155 rdf:type schema:DefinedTerm
156 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
157 schema:name Public Health and Health Services
158 rdf:type schema:DefinedTerm
159 sg:journal.1031325 schema:issn 1477-7517
160 schema:name Harm Reduction Journal
161 rdf:type schema:Periodical
162 sg:pub.10.1007/s10461-013-0593-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1020487771
163 https://doi.org/10.1007/s10461-013-0593-y
164 rdf:type schema:CreativeWork
165 sg:pub.10.1186/1477-7517-10-13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053050984
166 https://doi.org/10.1186/1477-7517-10-13
167 rdf:type schema:CreativeWork
168 sg:pub.10.1186/1477-7517-10-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045255166
169 https://doi.org/10.1186/1477-7517-10-7
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1016/j.drugalcdep.2013.03.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015042719
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1016/j.drugalcdep.2015.09.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031167283
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1016/j.drugalcdep.2018.05.030 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105468279
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1016/j.drugpo.2016.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051290979
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1016/j.drugpo.2016.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042879889
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.ijid.2010.06.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033372477
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.jcv.2014.05.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009645202
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.jhep.2016.07.042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047496931
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.vaccine.2012.02.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052670546
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/s0140-6736(10)60743-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010459885
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s2214-109x(17)30373-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1092332693
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s2214-109x(17)30375-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092329959
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s2468-1253(17)30249-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092596895
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/s2468-1253(17)30295-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092596896
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1093/ije/dyr050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040398875
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1111/jvh.12571 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039080936
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1177/1363459316660859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063997608
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1371/journal.pone.0103345 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019293991
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1371/journal.pone.0109282 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016621925
208 rdf:type schema:CreativeWork
209 https://doi.org/10.7196/samj.2017.v107i12.12623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100454929
210 rdf:type schema:CreativeWork
211 https://www.grid.ac/institutes/grid.11951.3d schema:alternateName University of the Witwatersrand
212 schema:name Division of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
213 National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
214 rdf:type schema:Organization
215 https://www.grid.ac/institutes/grid.413335.3 schema:alternateName Groote Schuur Hospital
216 schema:name Division of Hepatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Old Main Building, Groote Schuur Hospital, Observatory, Cape Town, South Africa.
217 rdf:type schema:Organization
218 https://www.grid.ac/institutes/grid.416657.7 schema:alternateName National Health Laboratory Service
219 schema:name National Institute for Communicable Diseases, 1 Modderfontein Road, Sandringham, Johannesburg, South Africa.
220 rdf:type schema:Organization
221 https://www.grid.ac/institutes/grid.452200.1 schema:alternateName Anova Health Institute
222 schema:name Anova Health Institute, 12 Sherborne Road, Parktown, Johannesburg, South Africa.
223 Division of Virology, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.
224 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...